Krystal Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. 

CEO
Krish S. Krishnan
CEOKrish S. Krishnan
Employees
275
Employees275
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2016
Founded2016
Employees
275
Employees275

KRYS Key Statistics

Market cap
4.02B
Market cap4.02B
Price-Earnings ratio
33.10
Price-Earnings ratio33.10
Dividend yield
Dividend yield
Average volume
459.09K
Average volume459.09K
High today
$143.44
High today$143.44
Low today
$136.44
Low today$136.44
Open price
$138.46
Open price$138.46
Volume
279.21K
Volume279.21K
52 Week high
$219.34
52 Week high$219.34
52 Week low
$122.80
52 Week low$122.80

KRYS News

TipRanks 1d
Krystal Biotech initiated with a Buy at Clear Street

Clear Street analyst Bill Maughan initiated coverage of Krystal Biotech (KRYS) with a Buy rating and $190 price target Krystal’s first commercial product, Vyjuv...

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

People also own

Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.